Opioid pharmaceutical compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Jul 25, 2003
filing date -
May 6, 1996
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding agent or partial mu-opioid agonist being included in a ratio to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combination is administered as prescribed, but which is less analgesically effective or less rewarding when administered in excess of prescription. Preferably, the combination product affects an opioid dependent individual differently from an opioid nave individual, and has a diminished likelihood of being associated with a life-threatening adverse drug reaction, especially in the opioid dependent individual.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully